SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The revenue slipped marginally during the September 2022 quarter. A decline of about Rs. 0.00 millions was observed as compared to Rs. 0.00 millions during the corresponding quarter last year.The Net Loss for the quarter ended September 2022 is Rs. -0.14 millions as compared to Net Loss of Rs. -0.34 millions of corresponding quarter ended September 2021 Operating profit Margin for the quarter ended September 2022 improved to -0.13% as compared to -0.32% of corresponding quarter ended September 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.68 0.00
Other Income 0.50 0.00 0.00 1.00 0.00 0.00 19.83 1.81 995.58
PBIDT -0.13 -0.32 -59.38 0.20 -0.64 -131.25 18.56 -1.53 -1313.07
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -0.13 -0.32 -59.38 0.20 -0.64 -131.25 18.56 -1.53 -1313.07
Depreciation 0.02 0.02 0.00 0.04 0.04 0.00 0.09 0.10 -10.00
PBT -0.15 -0.34 -55.88 0.16 -0.68 -123.53 18.47 -1.63 -1233.13
TAX -0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00
Deferred Tax -0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00
PAT -0.14 -0.34 -58.82 0.16 -0.68 -123.53 18.47 -1.64 -1226.22
Equity 52.39 52.39 0.00 52.39 52.39 0.00 52.39 52.39 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -91.07 0.00

Venmax Drugs&Pharma Share Price

26.05 1.39 (5.64%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×